Last updated on November 2019

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression


Brief description of study

The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT02600507

Find a site near you

Start Over

Clinical Site

Novi Sad, Serbia
3.26miles
  Connect »